Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebocontrolled trial with 9-month follow-up
In Chile, the prevalence of P. gingivalis, A. actinomycetemcomitans and T. forsythia in adults with chronic periodontitis was higher than 75%, 20% and 15% respectively Given the background in the literature, the selection of bacterial species resistant to the antibacterial treatment has been considered a global problem after the excessive use of these drugs. This leads to the search for new tools for the control of infectious diseases 8 . The use of probiotics has become more common in recent years. They are food supplements with microbial elements that have a physiologic effect on the organism that receives them.
The effect of the use of probiotics in the treatment of chronic periodontitis had been studied 13, 15, 16, 22, 26, 27, 29 .
Lactobacillus constitutes the most common bacterial genus used as a probiotic. In vitro studies have
shown that oral strains of Lactobacillus, including
Lactobacillus rhamnosus, display a strong inhibitory effect against the cariogenic species as well as against the Gram-negative periodontal pathogens 25 . Thus, the objective of our study was to evaluate the effects of Lactobacillus rhamnosus SP1 containing probiotic sachet and azithromycin tablets as an adjunct to nonsurgical therapy in clinical and microbiological parameters of chronic periodontitis. Patients, examiner and dentists who performed periodontal treatment were blinded to the study group assignment except for the study coordinator (Jorge Gamonal). The designation of the different groups was only revealed after study completion.
Material and methods

Participant population and inclusion and exclusion clinical criteria
The study coordinator handed out the study materials.
Clinical examination
Periodontal clinical examination consisted of 
Microbiological procedures
Microbiological procedures were performed by one expert (Nora Silva).
Subgingival plaque samples were dispersed by mixing for 45 seconds followed by a 10-fold serial dilution of the bacterial suspension in RTF, using PBS.
Procedures to detect and quantify P. gingivalis and T. forsythia were: Aliquots of 100 μL of the appropriate dilution (10 -2 and 10
) were plated on nonselective blood-agar, hemin-menadione medium. Plates were anaerobically incubated at 35°C for 14 days in a jar containing gas generator envelopes for the production of an anaerobic atmosphere (Anaerogen. Oxoid
Limited, Wade Road, Basingstoke, Hampshire, U.K.).
P r o c e d u r e s t o d e t e c t a n d q u a n t i f y A .
actinomycetemcomitans were: Aliquots of 100 μL of the appropriate dilution (undiluted and 10 actinomycetemcomitans was also primarily identified by colony morphology and catalase production.
Using direct method, total cultivable microbiota (total microbial load) was count on blood-agar, hemin-menadione medium and TSBV medium. The percentage of P. gingivalis and T. forsythia was obtained using the number of CFU/ml RTF on bloodagar hemin-menadione medium as a percentage of the total anaerobic count. The percentage of A.
actinomycetemcomitans was obtained using the number of CFU/ml RTF on TSBV as a percentage of the total anaerobic counts.
Final identification was made using PCR according to Ashimoto protocol.
Outcome variables
The primary outcome variable was change in CAL.
Secondary outcome variables were changes in PPD, PI 
Results
The flow chart of the study is shown in Figure 1 . patients followed the protocol of the study. Only one subject from the antibiotic group reported an adverse event (nausea).
Intergroup analysis
At baseline, no significant differences in demographic, medical and clinical characteristics were found between groups (p>0.05, Table 1 ).
Also, there were no intergroup differences in CAL, PPD, BOP, plaque accumulation, total cultivable microbiota and percentages of P. gingivalis, A. actinomycetemcomitans and T. forsythia at 3, 6, and 9 months follow-up (Table 2 Also, we observed a variation of the total cultivable microbiota, as seen in Table 2 . Compared with baseline, there was a significant reduction in the probiotic group at 6-month follow-up, while for the antibiotic group it occurred at all times (p<0.017).
In Table 3 the total cultivable microbiota decreased significantly in the probiotic and antibiotic groups. In the placebo group, the prevalence of subjects with P. gingivalis decreased. However, there were no significant differences between groups.
To our knowledge, this is the first study assessing and comparing the microbiological impact of the use of probiotics and antibiotics on the treatment of chronic periodontitis with a 9-month follow-up. In the probiotic group, we observed attachment gain, reduction of PPD, and reduction of plaque, which was not significant when compared with the other groups. This is partially consistent with studies using as probiotics: The administration of a probiotic with Streptococcus caused a significant reduction of CFU/ml of T.
forsythia, P. gingivalis, A. actinomycetemcomitans, Fusobacterium nucleatum and Prevotella intermedia
in the probiotic and placebo groups at 3-month follow-up, but without significant differences between In our study, we observed a reduction of the total cultivable microbiota at all follow-up times in the antibiotic group, but there were no significant differences with the other groups. Gomi, et al. 7 (2007) reported no intergroup differences in the prevalence of The major limitation of our study is the statistical power. This study could be too small to detect the real differences between the groups. An increase of the sample size is suggested.
In conclusion, the administration of L. rhamnosus 
